Leveraging a Precision Medicine Platform to Predict Novel Therapies for Malignant Peripheral Nerve Sheath Tumors

syn52369030

Created By NF Service nf-osi-service

studyName: Leveraging a Precision Medicine Platform to Predict Novel Therapies for Malignant Peripheral Nerve Sheath Tumors
dataStatus: Data Pending
initiative: Synergistic Idea Award
studyLeads: Sara Gosline Angela Hirbe David Largespada Christine Pratilas David Wood
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
institutions: Pacific Northwest National Laboratory
fundingAgency: CDMRP
relatedStudies: syn21984813 syn11638893 syn51907739 syn51117783
studyFileviewId: syn52369043
syn52369031
syn53503360
syn52369032
syn52369043
syn52369033
syn53696870

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Leveraging a Precision Medicine Platform to Predict Novel Therapies for Malignant Peripheral Nerve Sheath Tumors

syn52369030

Drop files to upload

Leveraging a Precision Medicine Platform to Predict Novel Therapies for Malignant Peripheral Nerve Sheath Tumors page is loading…